Australian

ACL.AX

Tags: AU Healthcare Medical - Diagnostics & Research

Australian Clinical Labs Limited Price (ACL.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

199,472,019

(0.8173)%

Market Cap of Australian (ACL.AX)

Market cap:

As of , ACL.AX has a market cap of . This makes ACL.AX the 281th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to pri... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $2.14-3.855
Market Cap 594.53M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

ceo: Ms. Melinda McGrath
IPO Date: May, 14, 2021
Country: AU
Currency: AUD
Headquaters: Clayton, VIC
Employees: 4900

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: